Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Tovorafenib |
| Trade Name | Ojemda |
| Synonyms | BIIB-024|TAK-580|MLN-2480|TAK580|DAY101|MLN2480 |
| Drug Descriptions |
Ojemda (tovorafenib) is an inhibitor of pan-Raf kinases, which interrupts RAF/MEK/ERK signal transduction pathways to inhibit tumor cell growth (PMID: 28082416, PMID: 30622172). Ojemda (tovorafenib) is FDA approved for use in patients 6 months or older with relapsed or refractory pediatric low grade glioma harboring BRAF fusion or rearrangement or BRAF V600 mutation (FDA.gov). |
| DrugClasses | RAF Inhibitor (Pan) 29 |
| CAS Registry Number | 1096708-71-2 |
| NCIT ID | C106254 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Alisertib + Tovorafenib | Alisertib Tovorafenib | 0 | 1 |
| Nivolumab + Tovorafenib | Nivolumab Tovorafenib | 0 | 1 |
| Paclitaxel + Tovorafenib | Paclitaxel Tovorafenib | 0 | 1 |
| Pimasertib + Tovorafenib | Pimasertib Tovorafenib | 0 | 1 |
| Rituximab + Tovorafenib | Rituximab Tovorafenib | 0 | 1 |
| Sapanisertib + Tovorafenib | Sapanisertib Tovorafenib | 0 | 1 |
| Selumetinib + Tovorafenib | Selumetinib Tovorafenib | 0 | 0 |
| Tovorafenib | Tovorafenib | 21 | 6 |
| Tovorafenib + Vinblastine | Tovorafenib Vinblastine | 0 | 1 |